OASIS-IPF (Idiopathic Pulmonary Fibrosis) Study
NCT03386994 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 204
Last updated 2020-11-09
Summary
Descriptive prospective non-interventional multicenter study based on newly collected data of Idiopathic Pulmonary Fibrosis patients followed-up for one year in secondary care settings (Pulmonology Services)
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Mireia Canals, +34607550925 · [email protected]
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-29
- Primary Completion
- 2019-09-16
- Completion
- 2019-09-16
Countries
- Spain
Study Locations
More Related Trials
-
Optimising Screening for Early Disease Detection in Familial Pulmonary Fibrosis
NCT05367349 ·Status: UNKNOWN
-
Observational Study to Evaluate Disease Course and Outcomes in Patients Treated With Esbriet (Pirfenidone) for Idiopathic Pulmonary Fibrosis (IPF) in Canada
NCT02552849 ·Status: COMPLETED
-
Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment
NCT05875532 ·Status: COMPLETED
-
A Study Based on Medical Records That Looks at the Characteristics of Idiopathic Pulmonary Fibrosis Patients Grouped by the Type of Medication They Are Taking
NCT03958071 ·Status: COMPLETED
-
Digital Auscultation Test - IPF Data Collection
NCT03503188 ·Status: COMPLETED ·Phase: PHASE4
-
Prevalence of Undiagnosed Chronic Obstructive Pulmonary Disease Sufferers in the Region of Murcia
NCT01380470 ·Status: COMPLETED
-
A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD)
NCT02100332 ·Status: COMPLETED
-
Quality of Life Study in Participants With IPF Under Pirfenidone Treatment
NCT03115619 ·Status: COMPLETED
-
Impact of Systemic Manifestations/Comorbidities on Clinical State, Prognosis, Utilisation of Health Care Resources in Patients With COPD
NCT01245933 ·Status: COMPLETED
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1
-
Idiopathic Pulmonary Fibrosis Registry China Study
NCT03666234 ·Status: UNKNOWN
-
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
NCT01915511 ·Status: RECRUITING
-
Observational Study to Evaluate Health Status of Chronic Obstructive Pulmonary Disease (COPD) Patients in Response to Real-life Treatments in Thailand
NCT01169727 ·Status: COMPLETED
-
Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis
NCT01695408 ·Status: COMPLETED
-
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
NCT03261037 ·Status: COMPLETED ·Phase: NA
-
Bronchial Inflammation in Patients With Bronchiolithis Obliterans
NCT01633385 ·Status: COMPLETED
-
A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
NCT05895409 ·Status: RECRUITING
-
Prospective Observation of Fibrosis in the Lung Clinical Endpoints Study
NCT01110694 ·Status: COMPLETED
-
Exhaled Breath Condensate Biomarkers and Cough in IPF
NCT02630940 ·Status: COMPLETED
-
Burden of Disease Among Subjects With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD)
NCT03436511 ·Status: COMPLETED
-
Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease
NCT05957198 ·Status: COMPLETED
-
Observational Multicenter Non-interventional Study on COPD Patients Treatment Strategies at the Time of Hospital Discharge and Within 12 Months of Follow-up on an Outpatient Primary Care Basement
NCT02346292 ·Status: COMPLETED
-
Early Detection of Acute Exacerbation in Patients With Idiopathic Lung Fibrosis - a Pilot Study
NCT03979430 ·Status: COMPLETED ·Phase: NA
-
Open-label Study With Bosentan in Interstitial Lung Disease
NCT00319033 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Chronic Obstructive Pulmonary Disease Case Finding in Community-pharmacies by Spirometry
NCT01576068 ·Status: UNKNOWN ·Phase: EARLY_PHASE1